Capecitabine
Capecitabine is a generic prescription drug used as chemotherapy to treat certain cancers, such as colorectal and breast cancer. It works by inhibiting nucleic acid synthesis in cancer cells. Available as oral tablets in 150mg and 500mg strengths, manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Capecitabine is a generic prescription drug used as chemotherapy to treat certain cancers, such as colorectal and breast cancer. It works by inhibiting nucleic acid synthesis in cancer cells. Available as oral tablets in 150mg and 500mg strengths, manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Capecitabine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Capecitabine — ANDA 204345 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204345"
}
]
|
| identifier | ANDA204345 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Capecitabine |
